GLPG (Galapagos) Net Sales Margin

Galapagos (GLPG) - corporate logo

A stable capital reserve allows Galapagos NV (GLPG) to pivot toward CAR-T therapy. This chart on GURU.Markets captures the effective sales margin with a metric value of 30.60, linking financial reports to price action. Development relies on leading European scientists and a team-based approach, while the implementation of energy-saving technologies in laboratories minimizes environmental impact.

Galapagos Corp (GLPG) Net Profit Margin: for the period 07/04/2022 - 05/08/2026

Metric breakdowns and analytics for Galapagos Corp (GLPG)

- market value and analyst target forecast:
- business market valuation indicators:
Comprehensive company analysis:Galapagos NV
Flagship merchandise of Galapagos Genomics

Galapagos NV's investments in a cutting-edge scientific environment and the academic freedom of its pharmacologists directly impact operational efficiency, as reflected in the ratio of net income to total revenue. This calculation allows for the filtering of market noise to assess the actual profitability of each unit of sales, which clearly demonstrates the net profit margin from product sales within the context of capital management.

Competitors of Galapagos NV (GLPG)

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|ANIP - Net Sales Margin|MNKD: Net Sales Margin|amphastar.com (AMPH) - Net Sales Margin|PCRX (Pacira Pharmaceuticals) - Net Sales Margin|Return on Sales by Net Profit ARS Pharmaceuticals, Inc. (SPRY)|Net Sales Margin TBPH|AQST (Aquestive Therapeutics) - Net Profit Rate|scPharmaceuticals, Inc. - Return on Sales by Net Profit|Net Profit Rate TECX|tonixpharma.com - Net Sales Margin|Net Profit Rate SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Net Margin|Return on Sales by Net Profit BioHarvest|Return on Sales by Net Profit EXOZ|Return on Sales by Net Profit Oramed Pharmaceuticals (ORMP)|Return on Sales by Net Profit ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Net Return on Sales|Net Sales Margin ABVC (ABVC BioPharma Inc)|CPIX - Return on Sales by Net Profit|Quantum BioPharma Corp - Net Sales Margin|FGEN (fibrogen.com) - Net Return on Sales|TELO (Telomir Pharmaceuticals) - Return on Sales by Net Profit|Rani Therapeutics Holdings - Net Profit Rate|Return on Sales by Net Profit SNYR|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma